Core Insights - Xylem Inc. reported adjusted earnings of $1.26 per share for Q2 2025, exceeding the Zacks Consensus Estimate of $1.14, marking a 16% year-over-year increase [1] - Revenues reached $2.30 billion, surpassing the consensus estimate of $2.21 billion, with a 6% year-over-year growth driven by strong order growth across segments [1] - Orders totaled $2.17 billion, reflecting a 4% year-over-year increase on both reported and organic bases [1] Segmental Performance - Water Infrastructure segment revenues were $650 million, up 3% year over year, with organic sales increasing by 4%, exceeding the consensus estimate of $640 million [2] - Applied Water segment generated revenues of $483 million, a 6% year-over-year increase, with organic sales up 5%, surpassing the consensus estimate of $459 million [3] - Measurement & Control Solutions segment revenues totaled $540 million, up 12% year over year, with organic sales increasing by 10%, exceeding the consensus estimate of $509 million [4] - Water Solutions and Services segment revenues reached $628 million, a 5% year-over-year increase, with organic sales also up 5%, surpassing the consensus estimate of $605 million [4] Financial Metrics - Adjusted EBITDA was $502 million, an 11.1% increase from the previous year, with a margin improvement to 21.8% from 20.8% [5] - Adjusted operating income rose to $401 million, a 13.9% year-over-year increase, with an adjusted operating margin of 17.4%, up from 16.2% [5] Balance Sheet and Cash Flow - Cash and cash equivalents at the end of Q2 were $1.17 billion, up from $1.12 billion at the end of December 2024; long-term debt decreased to $1.93 billion from $1.98 billion [6] - Net cash generated from operating activities in the first half of 2025 was $338 million, compared to $377 million in the same period last year; capital expenditure increased by 15% to $169 million [6] Shareholder Returns - Q2 EPS rose 16% to $1.26, supported by 6% revenue growth, with all segments showing year-over-year growth [7] - Dividends paid in Q2 amounted to $196 million, a 12% increase year over year, while share buybacks totaled $13 million [8] 2025 Guidance - Xylem raised its 2025 revenue outlook to $8.9 – $9.0 billion, up from the previous range of $8.7-$8.8 billion, indicating a 4-5% increase from the prior year [9] - Adjusted EBITDA margin is expected to be approximately 21.3-21.8%, reflecting an expansion of 70-120 basis points from the previous year [9] - Adjusted earnings are forecasted to be in the range of $4.70 – $4.85 per share, an increase from the previous expectation of $4.50–$4.70 [10]